Moderna’s patent dispute with the U.S. government gets at a crucial question: control over how the drug is used – MarketWatch

  1. Moderna’s patent dispute with the U.S. government gets at a crucial question: control over how the drug is used  MarketWatch
  2. Letter: Moderna vaccine patent  Longmont Times-Call
  3. Moderna offers NIH co-ownership of COVID vaccine patent amid dispute with government  CBS News
  4. Moderna COVID-19 vaccine patent dispute headed to court, U.S. NIH head says  Reuters
  5. The taxpayer seems to hold short end of vaccine patent fight between Moderna, NIH  The Boston Globe
  6. View Full Coverage on Google News